Vanguard Group’s Fennec Pharmaceuticals FENC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.03M | Buy |
967,092
+2,472
| +0.3% | +$20.5K | ﹤0.01% | 3023 |
|
|
2025
Q1 | $5.87M | Sell |
964,620
-5,134
| -0.5% | -$31.3K | ﹤0.01% | 3109 |
|
|
2024
Q4 | $6.13M | Sell |
969,754
-78,137
| -7% | -$494K | ﹤0.01% | 3182 |
|
|
2024
Q3 | $5.24M | Buy |
1,047,891
+21,237
| +2% | +$106K | ﹤0.01% | 3261 |
|
|
2024
Q2 | $6.27M | Buy |
1,026,654
+13,028
| +1% | +$79.6K | ﹤0.01% | 3154 |
|
|
2024
Q1 | $11.3M | Sell |
1,013,626
-126,437
| -11% | -$1.41M | ﹤0.01% | 2892 |
|
|
2023
Q4 | $12.8M | Buy |
1,140,063
+1,058,295
| +1,294% | +$11.9M | ﹤0.01% | 2810 |
|
|
2023
Q3 | $614K | Buy |
81,768
+1,895
| +2% | +$14.2K | ﹤0.01% | 3997 |
|
|
2023
Q2 | $705K | Buy |
+79,873
| New | +$705K | ﹤0.01% | 4012 |
|
|
2021
Q2 | – | Sell |
-111,372
| Closed | -$692K | – | 4439 |
|
|
2021
Q1 | $692K | Buy |
111,372
+13,864
| +14% | +$86.1K | ﹤0.01% | 4076 |
|
|
2020
Q4 | $727K | Buy |
97,508
+12,338
| +14% | +$92K | ﹤0.01% | 3896 |
|
|
2020
Q3 | $516K | Sell |
85,170
-5,094
| -6% | -$30.9K | ﹤0.01% | 3806 |
|
|
2020
Q2 | $754K | Buy |
+90,264
| New | +$754K | ﹤0.01% | 3679 |
|
|
2019
Q2 | – | Sell |
-45,067
| Closed | -$219K | – | 4174 |
|
|
2019
Q1 | $219K | Buy |
45,067
+3,458
| +8% | +$16.8K | ﹤0.01% | 3906 |
|
|
2018
Q4 | $266K | Sell |
41,609
-1,879
| -4% | -$12K | ﹤0.01% | 3845 |
|
|
2018
Q3 | $357K | Buy |
43,488
+2,868
| +7% | +$23.5K | ﹤0.01% | 3906 |
|
|
2018
Q2 | $424K | Buy |
+40,620
| New | +$424K | ﹤0.01% | 3848 |
|